Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment naïve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02946632
What this trial is testing

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type II
Korea University Anam Hospital 104
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Not applicableUnknownNCT05728476
What this trial is testing

Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaPars Plana VitrectomyConbercept
Tianjin Medical University Eye Hospital 102
Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Testing effectiveness (Phase 2)Looking for participantsNCT07671378
What this trial is testing

MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients

Who this might be right for
CLL (Chronic Lymphocytic Leukemia)
The First Affiliated Hospital with Nanjing Medical University 24
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Early research (Phase 1)Study completedNCT00405210
What this trial is testing

Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer

Who this might be right for
Primary DiseaseProstate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 38
Testing effectiveness (Phase 2)Study completedNCT02013817
What this trial is testing

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 43
Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Not applicableStudy completedNCT04151615
What this trial is testing

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boryung Pharmaceutical Co., Ltd 203
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01616524
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 880
Testing effectiveness (Phase 2)Study completedNCT01094548
What this trial is testing

Study of Tecemotide (L-BLP25) in Subjects With Slowly Progressive Multiple Myeloma With no Symptoms and Who Have Had no Chemotherapy

Who this might be right for
Multiple Myeloma
Merck KGaA, Darmstadt, Germany 34
Large-scale testing (Phase 3)Looking for participantsNCT07430306
What this trial is testing

Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 245
Testing effectiveness (Phase 2)Study completedNCT00446134
What this trial is testing

Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 278
Testing effectiveness (Phase 2)Study completedNCT01215643
What this trial is testing

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

Who this might be right for
Hepatitis CChronic Pain
Debiopharm International SA 340
Not applicableStudy completedNCT03939767
What this trial is testing

Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease

Who this might be right for
Wet Age-related Macular Degeneration
Bayer 1,563
Testing effectiveness (Phase 2)Study completedNCT00530920
What this trial is testing

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 85
Post-approval studies (Phase 4)Study completedNCT00127959
What this trial is testing

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Who this might be right for
HIV InfectionsHepatitis B
International Antiviral Therapy Evaluation Center 24
Next Page